Voxalatamab (JNJ-63898081) is a bispecific IgG4 monoclonal antibody designed to target both PSMA (Prostate-Specific Membrane Antigen) and CD3. This antibody exhibits anticancer activity and is specifically developed for research in prostate cancer. Voxalatamab facilitates the engagement of T-cells to PSMA-expressing tumor cells, offering a strategic approach for investigating immune-mediated cancer cell eradication.
Voxalatamab (JNJ-63898081) is a bispecific IgG4 monoclonal antibody designed to target both PSMA (Prostate-Specific Membrane Antigen) and CD3. This antibody exhibits anticancer activity and is specifically developed for research in prostate cancer. Voxalatamab facilitates the engagement of T-cells to PSMA-expressing tumor cells, offering a strategic approach for investigating immune-mediated cancer cell eradication.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
